Sponsor content
182 result(s) found, displaying 1 to 10
-
Prescription medicine registrationActive ingredients: deucravacitinib.
-
Jul-2026Prescription medicine evaluationActive ingredient: mezigdomide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-APX apixaban 5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APIXABAN-APX apixaban 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO SC nivolumab 600 mg in 5 mL (120 mg/mL) solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Augtyro has been approved for the treatment of adult patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).
-
Jan-2026Prescription medicine evaluationActive ingredient: nivolumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AUGTYRO repotrectinib 40 mg capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AUGTYRO repotrectinib 160 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle.